Strategic Planning Development Committees

Strategic Connections to New Jersey's Pharmaceutical Industry

One high level economic development and academic connection issue is UMDNJ's strategic relationship to New Jersey's important pharmaceutical industry. The purpose of this effort is to develop a university-wide strategy with the New Jersey pharmaceutical industry as a whole through a long-term lens.

• Roy Chaleff, Ph.D., Acting Vice President for Research OAA, Co-Chair
• William J. Welsh, Ph.D., Norman H. Edelman, Professor in Bioinformatics, Department of Pharmacology, UMDNJ-RWJMS & Director, The UMDNJ Informatics Institute , RWJMS, Co-Chair
• Michael L. Barnett, D.D.S., Oral Care Products Consultant, NJDS
• Carl E. Hock, Ph.D., Assistant Dean for Research & Acting Chair, Dept. of Cell Biology, SOM
• Jane Massey Licata, Ph.D., J.D., Interim Director Patents & Licensing
• Robert F. Orsetti, M.A., Assistant Vice President, Continuing/Outreach Education, CCOE
• Adam Perlman, M.D., M.P.H., F.A.C.P. Executive Director, ICAM, SHRP
• Andrew P. Thomas, Ph.D., Professor & Chairman, Dept. of Pharmacology & Physiology, NJMS